Graduation Level Topics   

  

1. ELISA-based Screening of Serum Antibodies to Common Viral Antigens
Project aim: evaluate presence and titer distribution of antibodies against a target viral antigen in a regional cohort. Methods (conceptual): use antigen–antibody immunoassays with appropriate controls and quantitative readout. Validation: compare seroprevalence with reported infection history and commercial kit data. Outcome: baseline seroepidemiology useful for local public health planning in India.

2. Rapid Lateral-Flow Test Evaluation: Sensitivity and Specificity Assessment
Aim: independent evaluation of a point-of-care lateral-flow device for a selected biomarker. Approach: blinded testing on characterized positive/negative samples and ROC analysis. Validation: analytical performance against reference laboratory methods. Relevance: informs adoption of rapid diagnostics for Indian primary-care settings.

3. Basic Flow-Cytometry Phenotyping of Peripheral Blood Immune Cells (Data Analysis Focus)
Aim: teach immunophenotyping concepts using provided FACS datasets. Approach: gating strategies, population quantification and statistical comparison across cohorts. Validation: reproducibility checks and cross-validation with published reference ranges. Relevance: builds data-analysis skills for immunology labs in India.

4. Comparative Study of Commercial Antibody Isotyping Kits
Aim: assess kit consistency for IgG/IgM/IgA subclass distribution reporting. Approach: side-by-side testing on panel sera and meta-analysis of kit outputs. Validation: concordance analysis and interpretation guidelines for clinical reports. Outcome: recommendations for laboratory procurement in Indian diagnostic centers.

5. Designing an Immunoassay Validation Plan for Small Diagnostic Labs
Aim: produce a complete validation plan (accuracy, precision, linearity, LOD conceptual) for a hypothetical immunoassay. Approach: define sample panels, QC regime and acceptance criteria. Outcome: a ready-to-use validation SOP template tailored for Indian regional labs and accreditation standards.

6. Assessment of Milk Immunoglobulin Levels in Dairy Populations
Aim: survey levels of specific antibodies in bovine/camel milk as an indicator of herd health or passive immunity. Approach: immunoassay-based quantitation and statistical correlation with vaccination history. Relevance: useful for Indian dairies to monitor herd immunity and calf protection programs.

7. Monoclonal Antibody Characterization — Binding Specificity and Cross-Reactivity (In Silico + Data Interpretation)
Aim: evaluate antibody specificity using sequence/epitope information and available experimental binding datasets. Approach: map epitope regions, predict cross-reactivity trends and propose orthogonal validation assays. Outcome: guidance on antibody selection for diagnostics in India.

8. Serological Surveillance of Zoonotic Pathogens at the Human–Animal Interface
Aim: community-level serosurvey for a zoonotic agent in people and livestock in a district. Approach: design sampling strategy, use serology for exposure assessment and compare human/animal seroprevalence. Impact: informs One Health interventions in Indian rural contexts.

9. Immunoassay-Based Detection of Food Allergens in Processed Products
Aim: screen local food items for presence of priority allergens (e.g., peanut proteins) using validated immunoassays. Approach: sampling across markets, analytical testing and result interpretation within labeling laws. Outcome: consumer safety data that can inform small-scale vendors in India.

10. Characterizing Vaccine-Induced Humoral Responses in a Student Cohort
Aim: measure post-vaccination antibody kinetics using immunoassays and correlate with age/gender factors. Approach: longitudinal sampling concept and data analysis plan. Relevance: teaches interpretation of vaccine immunogenicity and population heterogeneity in India.

11. Rapid Antigen Test Field-Performance Study in Community Clinics
Aim: field-assess lateral flow antigen tests for a common respiratory pathogen. Approach: prospective testing alongside clinical criteria and lab confirmation; analyze PPV/NPV in low-resource settings. Outcome: evidence-based recommendations for Indian primary-care use.

12. Comparative Analysis of Antibody Avidity Maturation Post-Infection vs Post-Vaccination
Aim: conceptual project to compare qualitative antibody maturation using avidity indices from serologic datasets. Approach: design analyses that infer maturation and implications for immunity. Relevance: supports understanding of long-term protection in Indian cohorts.

13. Evaluation of Diagnostic Antibody Panels for Autoimmune Markers
Aim: assess multi-analyte immunoassay panels used in autoimmune diagnostics. Approach: compare panel readouts against clinical diagnosis and single-marker assays. Outcome: recommendations for algorithmic testing in Indian clinical settings.

14. Public Health Utility of Serosurveys: Designing a District-Level Study
Aim: design a statistically robust serosurvey for an infectious disease in an Indian district. Approach: sampling strategies, assay selection, data weighting and interpretation for policymakers. Result: template survey plan to inform local disease control.

15. Immunoassay Cross-Validation: In-House vs Commercial Kit Performance
Aim: compare an in-house developed ELISA conceptually with a CE-marked kit using shared sample panels and statistical comparison. Outcome: decision framework on when in-house assays are acceptable for routine use in Indian labs.

16. Antibody Decay Modeling after Natural Infection: Data-Driven Project
Aim: use longitudinal serologic datasets to model antibody waning and predict time-to-susceptibility thresholds. Approach: non-linear mixed models and sensitivity analysis. Relevance: aids booster-dose policy discussions in India.

17. Designing a Quality Control Program for Immunodiagnostics in Remote Clinics
Aim: produce a QC program (controls, frequency, logs, proficiency testing) that is feasible in low-resource Indian settings. Approach: document templates and training guides. Outcome: helps improve diagnostic reliability outside urban centers.

18. Immunogenicity Screening of Plant-Derived Food Proteins (Allergenicity Focus)
Aim: screen candidate food proteins for potential cross-reactivity using in-silico epitope tools and available immunoassay data. Outcome: risk-prioritization report for novel food formulations in India.

19. Data Analysis Workshop: Interpreting ELISA Titer Distributions and Cutoffs
Aim: practical data-analysis project on determining appropriate cutoffs and clinical interpretation. Approach: ROC curve generation, bias assessment and reporting conventions. Relevance: strengthens lab reporting practices.

20. Assessing Maternal Antibody Transfer in Newborns from Vaccinated Mothers
Aim: investigate maternal–neonatal antibody transfer using paired mother–infant serum samples (conceptual design). Approach: comparative titer analysis and correlation with infant protection markers. Relevance: informs maternal immunization programs in India.

21. Exploratory Study: Autoantibody Prevalence in a Regional Population
Aim: screen a community cohort for selected autoantibodies to estimate background prevalence. Approach: assay selection and epidemiologic interpretation. Outcome: baseline data for regional clinical awareness.

22. Evaluation of Immunoassays for Detection of Veterinary Pathogen Antibodies
Aim: assess kits for veterinary surveillance in livestock (e.g., foot-and-mouth antibodies). Approach: compare kit results with clinical records and vaccination status. Relevance: improves herd health monitoring in India.

23. Characterizing Fc-Mediated Functions of Antibodies Using Public Datasets
Aim: analyze available data on antibody effector functions (ADCC, ADCP) and relate to clinical protection. Approach: meta-analysis and conceptual mapping of assay outputs to functional conclusions. Outcome: reading and interpretation skills relevant to modern immunology.

24. Rapid Diagnostic Test (RDT) Cold-Chain Vulnerability Assessment
Aim: examine how storage conditions affect RDT performance conceptually via literature and available QC data, and propose mitigation strategies for Indian climates. Outcome: guidance for supply-chain managers.

25. Field-Appropriate Sample Collection Kits for Serology in Rural Health Camps
Aim: design (conceptually) robust, low-cost sample-collection and transport kits for serosurveys in rural India, emphasizing biosafety and cold-chain minimization. Outcome: usable kit specifications for NGOs and health missions.

26. Antibody Landscape Mapping in Recovered vs Vaccinated Individuals
Aim: comparative project using serology datasets to map breadth and magnitude of antibody responses across cohorts. Approach: cluster analysis and visualization. Relevance: informs booster and vaccine choice strategies.

27. Evaluation of Multiplex Immunoassays for Simultaneous Biomarker Detection
Aim: compare multiplex versus singleplex assay outputs for panels relevant to infectious/parainfectious syndromes. Approach: assay concordance, interference checks and workflow advantages. Outcome: procurement guidance for tertiary labs in India.

28. Teaching Module: Immunoassay Troubleshooting and QC Interpretation
Aim: create a teaching module focused on interpreting QC failures and designing corrective actions (conceptual scenarios). Outcome: resource for training lab technicians in India.

29. Survey of Immunodiagnostic Capacity Across District Health Units
Aim: map available immunoassay platforms, staffing and QC practices across selected districts. Outcome: needs-assessment report to guide capacity-building investments in India.

30. Conceptual Validation of Milk Antibody Testing to Monitor Herd Disease Exposure
Aim: design an approach to use pooled milk antibody testing for herd-level surveillance. Approach: statistical pooling strategies and interpretation caveats. Relevance: cost-effective surveillance for Indian dairy cooperatives.

31. Antibody-Based Detection of Botanicals in Herbal Preparations (Authentication Study)
Aim: explore immunoassay-based authentication approaches for high-value botanicals where adulteration is an issue. Approach: assay selection and validation plan against reference materials. Outcome: consumer-protection tool concept for Indian herbal markets.

32. Practical Guide: Interpreting Serological Evidence in Clinical Case Reports
Aim: assemble case vignettes to practice serology interpretation (acute vs past infection, vaccination confounders). Outcome: improved clinical–lab communication templates for Indian hospitals.

33. Pilot Study: Surveillance of Antimicrobial-Resistance–Associated Immune Markers
Aim: conceptual project linking immune-response biomarkers with AMR infections using archived sera and microbiology results. Outcome: hypothesis-generating insights for Indian clinical research.

34. Evaluating the Use of Oral Fluids for Community-Level Serosurveillance
Aim: design comparison of oral fluid vs serum antibody detection sensitivity/specificity and propose sampling logistics. Relevance: less-invasive options for large Indian surveys.

35. Antibody Kinetics after Passive Immunotherapy: Data Interpretation Project
Aim: analyze available pharmacokinetic/serologic datasets to interpret passive-antibody decay and therapeutic windows. Outcome: translational insight for antibody therapy use in India.

36. Feasibility Study: School-Based Serosurveys for Vaccine Coverage Estimation
Aim: design a school sampling plan and assay strategy to estimate immunity levels among children. Outcome: operational plan for district health authorities in India.

37. Small-Scale Evaluation of Immune Markers as Predictors of Disease Severity
Aim: use clinical datasets to test whether early antibody or cytokine markers correlate with outcomes. Approach: statistical modeling and cross-validation. Relevance: triage tools in Indian hospitals.

38. Practical Guide: Implementing Proficiency Testing for Immunoassays in Regional Labs
Aim: design a PT exercise (conceptual) including sample panels, scoring and corrective action protocols. Outcome: template for regional quality improvement in India.

39. Antibody Profiling in Occupational Exposure Cohorts (Healthcare Workers)
Aim: analyze immune response patterns in occupationally exposed cohorts to assess risk and vaccine efficacy. Outcome: policy-relevant evidence for workplace protection in India.

40. Survey of Point-of-Care Immunoassay Adoption in Private Clinics
Aim: questionnaire-based study to map usage, training and reporting practices of POC immunoassays. Outcome: recommendations for standardized reporting across private Indian clinics.

41. Designing a Low-Cost Immunoassay Data-Recording App for Field Use
Aim: create a spec for a mobile app to capture RDT/ELISA results, GPS-tagging and QC logs for field teams. Outcome: prototype requirements useful for public-health programs in India.

42. Validation of Milk-Based Antibody Surveillance for Zoonotic Infections
Aim: conceptual evaluation of pooled milk sampling to monitor zoonotic pathogen exposure on dairy farms. Outcome: surveillance plan for veterinary public health in India.

43. Practical Review: Ethical Considerations in Community Serosurveys
Aim: develop a consent and reporting framework that respects privacy and interprets serology responsibly for communities in India. Outcome: an ethical protocol template.

44. Assessing Interference in Immunoassays from Endogenous Substances
Aim: analyze literature and available datasets to identify common assay interferences (heterophile antibodies, rheumatoid factor) and mitigation strategies. Outcome: guidance note for labs in India.

45. Pilot Data Analysis: Correlates of Neutralizing vs Binding Antibody Titers
Aim: analyze paired datasets to model relationship between binding-immunoassay readouts and functional neutralization. Outcome: conversion/interpretation guidelines for Indian labs lacking neutralization capacity.

46. Designing a Community Education Module on Antibody Testing Interpretation
Aim: produce layperson materials explaining what serology results mean and limitations. Outcome: outreach toolkit for public health messaging in India.

47. Evaluation Plan for Newborn Screening Immunoassays in Remote Clinics
Aim: propose logistics, QC and referral pathways to implement targeted neonatal immunoassays in rural Indian settings. Outcome: operational blueprint for pilot programs.

48. Conceptual Project: Using Immunoassays to Monitor Nutritional Biomarkers
Aim: design a serologic/blood-spot testing scheme for micronutrient deficiencies and interpret population-level results. Relevance: nutrition surveillance in India.

49. Data-Driven Review: Seasonal Variability in Antibody Titers and Public Health Implications
Aim: analyze time-series serology datasets to detect seasonal trends and inform vaccination timing strategies. Outcome: modelling brief for Indian health authorities.

50. Design of a Regional Immunology Training Curriculum for Laboratory Technicians
Aim: propose a competency-based curriculum covering immunoassay theory, QC and data reporting suited to district laboratories in India. Outcome: program outline and assessment rubrics.

​

Post-Graduation Level Topics 

​

1. Development and Validation of Multiplexed Bead-Based Immunoassays for Cytokine Panels
Aim: establish multiplex platforms to quantify broad cytokine signatures in clinical cohorts. Approach: assay panel design, cross-reactivity assessment and analytical validation. Expected outcome: high-dimensional immune profiling to stratify disease phenotypes in Indian hospitals.

2. Monoclonal Antibody Discovery Using B-cell Receptor Repertoire Sequencing and Computational Selection
Aim: mine human BCR repertoires from convalescent donors to identify candidate neutralizing antibodies. Approach: high-throughput sequencing, in-silico clustering of clonotypes and candidate prioritization for recombinant expression. Relevance: local antibody discovery pipelines for emerging Indian pathogens.

3. Engineering Fc Variants to Tune Antibody Effector Functions for Therapeutics
Aim: conceptualize design and assessment plans for Fc engineering to enhance or reduce ADCC/ADCP. Approach: in-silico design, functional assays (conceptual) and translational considerations. Outcome: roadmap for therapeutic antibody optimization in Indian biotech.

4. Nanobody Libraries and Applications: Discovery to Diagnostic Implementation
Aim: develop pipeline concepts for nanobody selection, characterization and incorporation into diagnostics. Approach: library screening approaches, stability profiling and assay integration. Relevance: low-cost diagnostic reagents tailored for Indian conditions.

5. Single-Cell Immune Profiling to Decipher Vaccine-Induced B- and T-Cell Responses
Aim: apply single-cell transcriptomics and B/TCR sequencing to map clonal responses post-vaccination. Approach: data integration to identify protective correlates. Outcome: mechanistic insights guiding vaccine strategies for Indian populations.

6. Computational Epitope Mapping and Rational Antigen Design for Next-Gen Vaccines
Aim: integrate immunoinformatics to predict conserved B- and T-cell epitopes and design antigen constructs for broad coverage. Validation: in-silico population-coverage analysis and proposed preclinical assays. Application: vaccine design for pathogens relevant to India.

7. Assay Development for Functional Antibody Readouts (Neutralization and ADCC Surrogates)
Aim: design validation plans for surrogate functional assays that correlate with gold-standard neutralization. Approach: assay standardization and cross-site reproducibility study. Outcome: scalable functional testing approaches for Indian labs lacking high-containment facilities.

8.  Systems Serology: High-Dimensional Mapping of Humoral Immune Profiles in Disease
Aim: combine multiple humoral features (isotype, subclass, FcR binding) into predictive models of protection or pathology. Approach: multiplexed assays and multivariate analyses. Relevance: translational biomarker discovery for Indian cohorts.

9. Designing Universal ELISA Platforms with Modular Capture Reagents
Aim: conceptualize modular assay platforms that can be rapidly retooled to new targets by swapping capture reagents. Approach: platform architecture, QC plans and rapid deployment strategies for outbreak response in India.

10. Synthetic Antigen Design to Improve Diagnostic Specificity in Endemic Settings
Aim: design truncated or chimeric antigens reducing cross-reactivity with endemic pathogens; validate specificity improvements conceptually. Outcome: improved diagnostics for Indian regions with co-endemic infections.

11. High-Throughput Single B-Cell Screening for Antibody Discovery
Aim: implement single-cell sorting and sequence recovery workflows to identify high-affinity antibodies. Approach: integrate bioinformatics for lineage tracing and candidate selection. Relevance: accelerate therapeutic antibody pipelines in India.

12. Integrated Immunomonitoring in Clinical Trials: Assay Harmonization and Biomarker Discovery
Aim: design harmonized immunomonitoring panels and data pipelines for multi-site trials in India. Approach: assay standardization, batch-effect control and biomarker validation strategy. Outcome: clear immunological endpoints for trial readouts.

13. Design of Stable, Thermotolerant Immunoassay Reagents for Low-Resource Settings
Aim: engineer reagent formulations and labels that maintain performance without cold-chain. Approach: stress-testing concepts and stabilization strategies. Impact: increases diagnostic reach in Indian rural health systems.

14. Neutralizing Antibody Escape Mapping via Deep Mutational Scanning Concepts
Aim: conceptualize DMS-based mapping of antigenic escape and its incorporation into vaccine update decisions. Approach: data-driven antigen design workflows and surveillance integration in India.

15. Multiplexed Point-of-Care Immunodiagnostics Using Microfluidic Platforms
Aim: design microfluidic cartridge concepts that perform multi-analyte immunoassays with minimal operator steps. Approach: assay miniaturization, reagent integration plan and field validation strategy. Relevance: comprehensive bedside diagnostics for Indian clinics.

16. Engineering Cell-Based Immunoassays Using Reporter Cell Lines
Aim: devise reporter cell systems that respond to antibody-mediated receptor engagement (e.g., FcγR activation) for functional readouts. Approach: conceptual line engineering and assay validation roadmap. Outcome: deployable functional assay systems for immunotherapy assessment.

17. Design and Validation Framework for Immunoassays Detecting Immune Checkpoint Molecules
Aim: develop assay concepts to quantify checkpoint proteins and soluble receptors in patient samples. Approach: antibody pair selection, standardization and correlation with clinical outcomes. Application: immunotherapy monitoring in oncology centers across India.

18. Phage-Display Guided Vaccine Antigen Design: From Library to Lead Antigen
Aim: use phage-display selections to identify immunodominant mimotopes and incorporate them into subunit vaccine concepts. Approach: selection strategy, antigen engineering and immunogenicity assessment plan. Relevance: rapid antigen discovery for regional pathogens.

19. Designing Surveillance Programs Using Serologic Multiplexes for Multiple Pathogens
Aim: build multiplex surveillance panels for co-circulating pathogens and model population immunity landscapes. Approach: panel design, analytics and public-health integration. Outcome: cost-effective serosurveillance framework for Indian public health.

20. Antibody Engineering to Reduce Immunogenicity of Therapeutic Proteins
Aim: conceptual plan for de-immunizing therapeutic proteins by removing T-cell epitopes while preserving function. Approach: in-silico epitope mapping and proposed validation cascade. Relevance: safer biologics development in India.

21. High-Content Imaging Coupled with Immunolabeling to Map Tissue Immune Microenvironments
Aim: implement multiplex immunofluorescence panels to spatially map immune cells in tissue biopsies. Approach: panel design, image quantification pipelines and clinical correlation strategies. Application: tumor immunology and infectious pathogenesis studies in India.

22. Standardizing Neutralization Assays Using Pseudovirus Systems for BSL-2 Labs
Aim: develop validation plans to adopt pseudovirus neutralization assays as surrogates for live-virus tests. Approach: assay comparability studies and reference standard development. Outcome: broadened neutralization testing capacity for Indian institutions.

23. Computational Design of Bispecific Antibodies for Therapeutic Use
Aim: design conceptual bispecific formats to redirect immune effector cells to disease targets, with in-silico modeling of binding geometry and developability. Outcome: pipeline plan for preclinical development in India.

24. Engineering Novel Adjuvant Platforms: Rational Design and Immunoprofiling
Aim: conceptualize new adjuvant formulations targeting specific innate pathways to direct adaptive responses. Approach: immunoprofiling metrics and safety evaluation plan. Relevance: tailor vaccines for Indian population immunological contexts.

25. Systems Immunology of Severe Disease: Integrating Multi-Omics to Identify Therapeutic Targets
Aim: integrate transcriptomic, proteomic and immune-phenotyping datasets to identify dysregulated pathways in severe cases of a disease. Approach: network analysis to nominate targets for immunomodulation. Application: targeted therapy trials in Indian hospitals.

26. Developmental Pipeline for Recombinant Antibody Therapeutics in India
Aim: outline a translational roadmap from discovery to IND/clinical trial for locally developed antibodies. Approach: preclinical characterization, safety assessment and regulatory navigation in Indian context. Outcome: practical commercialization plan.

27. Advanced Assay Design to Differentiate Vaccine-Induced from Infection-Induced Antibodies
Aim: propose antigen combinations and analytic strategies to discriminate vaccine responses from natural infection in serosurveillance. Approach: multiplex design and validation cohorts. Impact: more accurate epidemiology for Indian vaccination programs.

28. Engineering Glycoforms of Antibodies to Modulate Effector Functions
Aim: design approaches to control antibody glycosylation and study resulting functional consequences. Approach: host-cell engineering concepts and functional validation roadmap. Relevance: improving therapeutic antibody performance for Indian manufacturers.

29. High-Throughput Functional Screening of T-Cell Epitopes Using Barcoded Libraries
Aim: conceptualize multiplex assays to map T-cell reactivity to many epitopes simultaneously and prioritize vaccine candidates. Approach: sample cohorts, data deconvolution and immunodominance analysis. Application: vaccine design for regionally prevalent strains.

30. Validation of Dried Blood Spot (DBS) Immunoassays for Large-Scale Serosurveys
Aim: assess performance trade-offs of DBS versus serum for key antibody assays and propose correction models. Outcome: operational guidance enabling wide-area serosurveys in Indian settings.

31. Engineering Antibody Fragments (Fab, scFv) for Improved Tissue Penetration Diagnostics
Aim: design fragment reagents for imaging or intra-tissue detection and plan validation in preclinical tissue panels. Outcome: enhanced diagnostic reagents for Indian clinical research.

32. Integrative Machine-Learning for Predicting Vaccine Responders from Baseline Immune Profiles
Aim: build and validate ML models that predict individuals likely to mount protective responses, using baseline multi-parameter datasets. Application: targeted vaccination strategies in India.

33. Designing Immunoassays for Detecting Immunotherapy-Related Biomarkers
Aim: select and validate soluble markers predictive of response or toxicity to checkpoint inhibitors. Approach: multiplex assay design and clinical correlation plan. Relevance: oncology centers in India deploying immunotherapies.

34. Nanoparticle-Enabled Immunoassays for Enhanced Sensitivity in Field Diagnostics
Aim: develop concepts for nanoparticle signal amplification in POC assays and design validation pathways for ruggedness and specificity. Outcome: sensitive, low-resource diagnostics for Indian use.

35. Engineering Mucosal Immunity: Design of Delivery Platforms and Immunoprofiling
Aim: conceptualize antigen/adjuvant formulations for mucosal routes and design assays to measure mucosal antibody and cellular responses. Application: vaccines targeting enteric or respiratory pathogens in India.

36. Forensic Immunoassays: High-Specificity Tests for Biological Fluid Identification
Aim: develop conceptual workflows combining protein markers to identify body fluids in forensic samples. Approach: marker selection, validation on degraded matrices and legal reporting considerations. Impact: supports forensic labs in India.

37. Antibody Drug Conjugate (ADC) Design — Target Selection and Payload Matching
Aim: propose ADC concepts for specific Indian cancer indications, including target expression profiling and payload strategy. Approach: in-silico target validation and translational development plan.

38. Engineering Immune-Sensor Cells for Environmental Biosensing Applications
Aim: design immune-reporter cell lines that respond to biologically relevant toxins/pathogens with measurable outputs and propose containment and deployment strategies. Relevance: environmental monitoring needs in India.

39. High-Resolution Mapping of B-Cell Epitopes Using Peptide Arrays
Aim: map linear epitope landscapes in population cohorts to inform vaccine and diagnostic design. Approach: array design and data analysis plan. Outcome: epitope maps for Indian pathogen strains.

40. Validation Strategy for Immunoassays Used in Therapeutic Monitoring
Aim: design validation frameworks for assays that measure therapeutic antibody levels or anti-drug antibodies. Approach: establishing clinical cutoffs, inter-assay harmonization and impact on dosing decisions. Application: Indian biologic therapy monitoring.

41. Rational Design of Antibody Libraries Using Human Repertoire Data
Aim: construct synthetic libraries that reflect human CDR diversity patterns and propose screens for desired biophysical/functional profiles. Outcome: accelerated discovery pipelines for Indian biopharma.

42. Assay Development for Cellular Immunity Readouts (ELISpot/FluoroSpot Standardization)
Aim: harmonize and validate protocols and scoring methods for cellular response assays across sites. Approach: reference reagents, inter-lab comparisons and analysis pipelines. Outcome: robust cellular immunoassays for clinical research in India.

43. Integrative Serology and Genomics to Identify Correlates of Protection
Aim: combine host genomics and humoral data to identify genetic modulators of vaccine response. Approach: cohort selection, integrative analysis and candidate validation. Relevance: personalized vaccine strategies for Indian populations.

44. Designing Passive Immunization Strategies Using Polyclonal Hyperimmune Preparations
Aim: outline a translational plan to produce hyperimmune immunoglobulin preparations against regional pathogens, covering donor selection, potency assays and regulatory pathway. Outcome: emergency therapeutics roadmap for India.

45. Development of Antigen-Detecting Immunoassays with High Specificity in Co-endemic Regions
Aim: engineer tests that minimize cross-reactivity where multiple related pathogens circulate; propose orthogonal marker combinations and validation cohorts. Application: improved diagnostics for complex endemic settings in India.

46. High-Throughput Affinity Maturation Using Display Technologies: Strategy and Analysis
Aim: plan a campaign using yeast or phage display to mature antibody leads, including selection stringency design and sequence-function mapping. Relevance: therapeutic antibody development in Indian start-ups.

47. Designing Immunomonitoring Pipelines for Cellular Therapies (CAR-T) in India
Aim: develop standardized assays to monitor CAR-T cell persistence, phenotype and function post-infusion. Approach: assay panels, scheduling and clinical interpretation framework for Indian oncology centers.

48. Assay Harmonization for Global Serology Comparisons: Inter-lab Reference Materials
Aim: propose reference materials and cross-validation studies enabling comparison of serology data across Indian labs and international consortia. Outcome: data comparability for multi-site studies.

49. Computational Modeling of Antibody–Antigen Interactions to Guide Candidate Selection
Aim: use structural modeling and binding-energy prediction to prioritize antibody candidates before experimental testing. Outcome: resource-efficient discovery workflows for Indian research groups.

50. Roadmap for Building an Indigenous Immunotech Ecosystem: From Reagents to Diagnostics
Aim: create a strategic plan for India to develop end-to-end immunotech capabilities — reagent generation, assay development, manufacturing and regulatory pathways. Outcome: policy and investment brief to catalyze domestic diagnostic and therapeutic capacity.